Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02284789 · ClinicalTrials.gov registry record · NA
Colorado Adult Joint Assessment Scale (CAJAS) Validation
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02284789 is a NA study that has completed, run by Bayer. The registered enrollment target is 30 participants.
The verdict
NCT02284789, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
To obtain evidence of content validity and reliability of the Colorado Adult Joint Assessment Scale (CAJAS), a clinician-reported outcome (ClinRO) measure, as adapted for use in a population of adults with moderate to severe hemophilia A treated with coagulation factor VIII (FVIII) therapy as secondary prophylaxis or episodic treatment.
Interventions
- OTHER Colorado Adult Joint Assessment Evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02284789
The ClinicalTrials.gov registry entry for NCT02284789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colorado Adult Joint Assessment Evaluation is the first listed.
NCT02284789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02284789 about?
NCT02284789 is a clinical study titled "Colorado Adult Joint Assessment Scale (CAJAS) Validation". To obtain evidence of content validity and reliability of the Colorado Adult Joint Assessment Scale (CAJAS), a clinician-reported outcome (ClinRO) measure, as adapted for use in a population of adults with moderate to severe hemophilia A treated with coagulation factor VIII (FVIII) therapy as second...
What is the current status of trial NCT02284789?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-02. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02284789?
The interventions under investigation include: Colorado Adult Joint Assessment Evaluation (OTHER).
Who is sponsoring clinical trial NCT02284789?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.